Working independently and in a matrix, this role will lead the development of antigen antibodies against novel targets discovered by Oxford BioTherapeutics, headquartered in the UK. They will be involved in multiple aspects of the production of recombinant proteins, monoclonal antibodies, multi-specific scaffolds and novel protein modalities to enable all aspects of early discovery and validation research.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree
Number of Employees
11-50 employees